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Directed specification and prospective isolation of chondrogenic paraxial mesoderm progeny from human
pluripotent stem (PS) cells have not yet been achieved. Here we report the successful generation of
KDR
2PDGFRa
1progenyexpressingparaxialmesodermgenesandthemesendodermreporterMIXL1-GFP
inachemicallydefinedmediumcontainingthecanonicalWNTsignalingactivator,BMP-inhibitor,andthe
Nodal/Activin/TGFb signaling controller. Isolated (GFP
1)KDR
2PDGFRa
1 mesoderm cells were sensitive
tosequentialadditionofthethreechondrogenicfactorsPDGF,TGFbandBMP.Undertheseconditions,the
cells showed robust chondrogenic activity in micromass culture, and generated a hyaline-like translucent
cartilage particle in serum-free medium. In contrast, both STRO1
1 mesenchymal stem/stromal cells from
adult human marrow and mesenchymal cells spontaneously arising from hPS cells showed a relatively
weaker chondrogenic response in vitro, and formed more of the fibrotic cartilage particles. Thus, hPS
cell-derived KDR
2PDGFRa
1paraxial mesoderm-likecells havepotentialinengineered cartilage formation
and cartilage repair.
H
uman joint cartilage lacks the intrinsic capacity to repair itself through regeneration by the resident
chondrogenic progenitors of the articular cartilage (hyaline cartilage) that confers high resistance to
repetitive compressive and shear forces. One promising treatment for repairing damaged cartilage is
the transplantation of chondroprogenitor cells, such as the dedifferentiated chondrocytes and mesenchymal
stem/stromal cells (MSCs), which are typically isolated from bone marrow. However, because of their limited
supply, these adult stem/progenitor cells require ex vivo expansion to be used in current cellular therapies. This
expansion reduces the cells’ differentiation potential, increases the risk of oncogenic transformation of the cells
1,
and results in the production of fibrocartilage with poor biomechanical properties
2.
The pluripotent embryonic stem (ES) cells and the recently established induced pluripotent stem (iPS) cells
(designated collectively, pluripotent stem cells or PS cells) have considerable advantages over adult stem/pro-
genitor cells, due to their capacities of unlimited proliferation and multi-lineage differentiation. Chondrogenesis
occurs predominantly during embryogenesis, and chondrocytes are mainly derived from the precursors of the
following three different embryonic cell lineages: sclerotome (somitic paraxial mesoderm), limb mesenchyme
(lateral plate mesoderm), and ectomesenchyme (cranial neural crest). Because mouse (m)ES cell differentiation
can mimic early embryogenesis
3,4, we have postulated that human (h)PS cells can also be directed to differentiate
into one of those embryonic chondrocyte precursor types. This differentiation would allow a large number of
robustly chondrogenic cells to be obtained without expansion prior to transplantation or other applications.
Chondrocyte differentiation from hES cells has already been reported, but most of the research involves
spontaneous differentiation culture that includes undefined medium components and/or long-term differenti-
ation culture in the presence of other cell types; both types of culture obscure the underlying mechanisms and
would produce artifacts
5. Reports have revealed that mesodermal genes are expressed in parallel during the
generation of chondrocytes or their precursors
6,7. However, no report has confirmed this mesodermal origin
by lineage tracing using genetic means and/or by fluorescence-activated cell sorting (FACS), and none has
compared the chondrogenic activity between the progeny and the gold standard MSCs.
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tightly regulated by Wnt, bone morphogenetic protein (BMP) and
Nodal/Activin/transforming growth factor-b (TGFb) signaling dur-
ing early embryogenesis. We previously reported that the activation
ofWntsignalingandinhibitionofBMPsignalingleadtotheeffective
specification from mES cells of chondrogenic somitic and/or rostral
presomitic mesoderm that express platelet-derived growth factor
receptor-a (PDGFRa) but not vascular endothelial growth factor
receptor-2 (FLK1 or KDR)
8. In this study, we report the signaling
requirementsforhPScellstogenerateparaxialmesoderminachem-
ically defined medium (CDM) and the cell surface markers that are
effective in prospectively isolating paraxial mesoderm by FACS.
From the investigation of the signaling requirements for the isolated
mesodermtogeneratecartilageparticlesinaserum-freemedium,we
also report that hPS cell-derived mesoderm has a potentially greater
capacity to produce hyaline cartilage-like particles in culture than
either adult bone marrow MSCs or the PScell-derived mesenchymal
progeny prepared using conventional methods.
Results
Specification of paraxial mesoderm from mouse and human PS
cells by canonical WNT signaling without BMP signaling. The
specification of paraxial mesoderm from hES cells by the
manipulation of signaling was monitored by the expression of the
specific transcripts for MEOX1, MEOX2, PARAXIS (TCF15) and
MESP2 and the emergence of the KDR
2PDGFRa
1 progeny. Mouse
ES cells that were differentiated in CDM in the presence of WNT3a
and Noggin gave rise to FLK1/KDR
2PDGFRa
1 paraxial mesoderm
cellswith robustchondrogenic activity
8. However, H9 (Supplementary
Fig.1A)andMixl1-GFPhEScellsthatdifferentiatedinthepresenceof
WNT3a1Noggin or WNT5a1Noggin in CDM generated few
KDR
2PDGFRa
1 progeny and only poorly specified paraxial me-
soderm as determined by the expression of MEOX1 and TCF15.
WNT primarily exerts its biological effects through b-catenin-
mediated transcription (i.e., the canonical pathway), which can also
be activated by the inhibition of glycogen synthase kinase (GSK)3b,
which triggers the degradation of b-catenin
9. Therefore, we instead
initiated the differentiation of H9 hES cell in the presence of a small-
molecule GSK3 inhibitor (BIO) and Noggin (hereafter designated as
BIO 1 Noggin or BION) (Fig. 1A). As a consequence, the proportion
of KDR
2PDGFRa
1 cells (BION, Fig. 1B) and the levels of MEOX1
and TCF15 transcripts (BION, Fig. 1C, Supplementary Fig. 1A) by day
8 increased significantly. In the presence of Noggin, the GSK3
inhibitors Acetoxime-BIO (AceBIO) and CHIR99021 (CHIR) were
also effective, but the inactive analogue of BIO, 1-methyl-BIO
(MeBIO), was not effective (Fig. 1B, C). These results suggest that
paraxial mesoderm specification during hES cell differentiation is
achieved by the activation of canonical WNT signaling and the
inhibition of BMP signaling.
TheemergenceoftheKDR
2PDGFRa
1progenyfromH9hEScells
was apparent from day 4 and reached a peak at around day 6 when
differentiated in the presence of BIO 1 Noggin (Supplementary Fig.
1B). Consistently, the early mesendodermal markers T and MIXL1
showedapatternoftransientexpressionthatpeakedaroundday2to
3,whileexpressionofMEOX1andTCF15increasedfromday6(blue,
Fig.1D).Theremoval ofNoggin hadnoeffectontheexpression ofT
and elevated the expression ofMIXL1 (red). In contrast, the removal
of Noggin strongly induced the expression of the extraembryonic
and/or lateral plate mesoderm genes FOXF1 and PRRX1 from
around day 4 and suppressed that of MEOX1 and TCF15. In either
case,thepluripotentstemcellmarkergenesNANOGandOCT4were
downregulated during differentiation.
Fine tuning of Nodal/Activin/TGFb signaling for efficient
specification of paraxial mesoderm from mouse and human PS
cells. In addition to WNT and BMP signaling, Nodal signaling is
involved in gastrulation and germ layer specification in a dose-
dependent manner
10. To further improve the specification of
paraxial mesoderm, we adjusted the level of Nodal signaling
during differentiation by titrating Activin A, a Nodal mimic, or
SB431542, a small-molecule inhibitor of the Nodal/Activin/TGFb
receptor, against BIO 1 Noggin.
We first tested H9 and Mixl1-GFP hES cells
11. When H9 hES cells
were differentiated under varying concentrations of Activin A and
SB431542inthepresence ofBIO1Noggin,theexpressionprofile of
MEOX1 and TCF15 displayed a parabolic distribution with a peak of
approximately 0 ng/ml Activin A/0 mM SB431542 (blue Fig. 2A).
However, for the Mixl1-GFP hES cell progeny (red), the peak was
reached at 2–3 mM SB431542 in the presence of BIO 1 Noggin (the
condition hereafter referred to BIO 1 SB 1 Noggin or BIOSN). The
BIO 1 SB (BIOS) or BIO 1 Noggin (BION) condition showed
weaker enhancing effects on MEOX1 and TCF15 expression than
didtheBIOSNcondition(Fig.2B).Similarly,AceBIOandCHIRalso
induced MEOX1 and TCF15 expression in the presence of SB 1
Noggin (AceBioSN, CHIRSN).
The requirement to modulate Nodal/Activin/TGFb signaling for
the maximal specification of paraxial mesoderm in the presence of
BIO 1 Noggin seems to apply to both mouse and human PS cells.
The HK1 hiPS cells required SB431542 at 1–2 mM (i.e., BIO 1 SB 1
Noggin) (green, Fig. 2A). In contrast, the Bry-GFP mES cells
required Activin A at 2–5 ng/ml (i.e., BIO 1 Activin 1 Noggin)
(Supplementary Fig. 2A). The MEL1 hES cells were similar to the
H9 hES cells because they did not require exogenous Activin or
SB431542 for the specification of paraxial mesoderm (i.e., BIO 1
Noggin) (Supplementary Fig. 2B).
As in the case of mES cell differentiation
8, the canonical WNT
signaling activated by BIO induced the expression of NODAL and
BMP4duringhPScelldifferentiation(Fig.2C,D).AlthoughtheBIO-
induction of BMP4 was dependent on endogenous BMP activity as
demonstrated by reduced expression in the presence of Noggin, the
induction of NODAL was independent of such BMP activity as
shown by the lack of effect of Noggin (BIO-red vs. BION-blue,
Fig. 2C). However, the level of induced NODAL varied considerably
among hPS cell lines. This variation appeared to correlate with the
requirement for either Activin or SB432542 for the maximal spe-
cification of MEOX1-expressing paraxial mesoderm (Fig. 2D). For
example, the Mixl1-GFP hES cells (yellow) required SB432542 for
paraxial mesoderm specification and induced the NODAL transcript
more than the H9 hES cells (red). Therefore, the level of WNT-
induced NODAL expression may determine the requirement of exo-
genousActivinAorSB431542forthemaximalspecificationofpara-
xial mesoderm from hPS cells by canonical WNT signaling.
The KDR
2PDGFRa
1 progeny developed under BIO 1 Noggin
1/2 SB431542/Activin are mesendoderm derivatives. As for
mES cells
8, the KDR
2PDGFRa
1 progeny generated from hPS cells
under conditions in which expression of MEOX1 and TCF15 is
optimized, i.e. BIO 1 Noggin (BION) or BIO 1 SB 1 Noggin
(BIOSN), may be enriched in paraxial mesoderm. In support,
when KDR
2PDGFRa
1 and KDR
2PDGFRa
2 progeny generated
from H9 hES cells under BION conditions were isolated by FACS
(Fig. 3A), the paraxial mesoderm transcripts, e.g., MEOX1, MEOX2,
TCF15 and MESP2, were found to be enriched in the
KDR
2PDGFRa
1 cell fraction (P1, Fig. 3B). Furthermore, after 3–
5daysinculture,cellsappearedthatexpressedMEOX1proteinatthe
correct intracellular locus of the nucleolus (BION, pink spots,
Fig. 3C), suggesting that, analogous to mouse rostral paraxial
mesoderm (FLK1/KDR
2PDGFRa
1)
8, human paraxial mesoderm is
also KDR
2PDGFRa
1. In addition, lateral plate/extraembryonic
mesoderm was specified under BIO but not BION conditions
(Fig. 1D), and MEOX1 protein was not detected in cells generated
under BIOconditions (Fig. 3C). Theseobservations alsosuggest that
www.nature.com/scientificreports
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is responsible for the mesodermal activities of the KDR
2PDGFRa
1
progeny generated under BION or BIOSN conditions.
The MIXL1-expressing early mesendoderm cells generated at the
primitive streak are common precursors of mesoderm and definitive
endoderm
12. Later MIXL1 expression stays in the endoderm. The
GFP (green fluorescence protein)
1 EB cells from Mixl1-GFP hES
cellswerethusconsideredtobemesendodermand/ormesendoderm
derivatives such as early progenitors committed to mesoderm or
endoderm, and definitive endoderm. FACS analyses showed
that the conditions supporting paraxial mesoderm specification,
i.e., BIOSN, AceBIOSN, or CHIRSN, resulted in the development
of KDR
2PDGFRa
1 cells that were also GFP
1 by 6–8 days of differ-
entiation (Fig. 3D, Supplementary Fig. 3A). The GFP
1 and
PDGFRa
1 progeny were first detected on day 2 and day 4, respect-
ively, during differentiation under BIOSN conditions, and their
Figure 1 | Directed specification of paraxial mesoderm in a chemically defined medium. (A) Differentiation protocol for hPS cells. (B, C) GSK3
inhibitorandNoggin-dependentspecificationofparaxialmesodermandassociatedchangesintheprogenitorprofileafter8daysofdifferentiationofH9
hES cells. (B) FACS analysis. (C) RT-PCR with MEOX1 and TCF15 primers. No, None; N, Noggin; AceBIO/Ace-BIO, Acetoxime-BIO; CHIR,
CHIR99021; MeBIO, Methyl-BIO. (D) Time-dependent differentiation of H9 hES cells in the presence of no factors (No), BIO, and BIO 1 Noggin
(BION). Specification of mesoderm was monitored by RT-PCR.
www.nature.com/scientificreports
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1
progeny generated were GFP
1 on day 4, at which time 75% of them
werealsoKDR
1.TheGFPlevelinthePDGFRa
1cellfractiondimin-
ishedastheMIXL1transcriptleveldeclined(SupplementaryFig.3B)
as did the KDR level, suggesting the presence of mesendoderm deri-
vatives in the GFP
1KDR
2PDGFRa
1 fraction at day 8. The overall
kinetics of mesodermal gene expression and the concomitant loss of
pluripotency transcripts, and the Noggin requirement for paraxial
mesoderm gene expression were similar to those of the H9 hES cells
(Supplementary Fig. 3B).
Furthermore, the GFP
1KDR
2PDGFRa
1 mesendodermal cell
fraction isolated from day 8 Mixl1-GFP EBs formed under BIOSN
conditions (GFP1P1, Fig. 3E), was enriched in the MEOX1 tran-
script (Fig. 3F), as was seen with H9 hES cells. There was no sign of
specification of lateral plate/extraembryonic mesoderm from the
Mixl1-GFP hES cells under BIOSN conditions (Supplementary Fig.
3B). Therefore, the KDR
2PDGFRa
1 progeny that were also MIXL1-
GFP
1 were enriched in paraxial mesoderm.
These results indicate that the KDR
2PDGFRa
1 progeny induced
fromhEScellsundertheoptimalconditionforexpressionofMEOX1
and TCF15 (BION, BIOSN, etc) are mesendoderm derivatives
enriched in paraxial mesoderm but not lateral plate/extraembryonic
mesoderm.
Factor-dependent chondrogenesis from the isolated KDR
-PDGFRa
1
paraxial mesoderm.Depending on which extracellular signaling factors
are present, chondrogenesis from the mesenchymal precursor cells pro-
ceeds through multiple developmental stages: mesenchymal conden-
sation, chondroprogenitor cell development and proliferation, and
chondrocyte development and maturation
13,14.T h eK D R
2PDGFRa
1
Figure 2 | Fine-tuning Nodal/Activin/TGFb signaling for efficient specification of paraxial mesoderm. (A) Activin A/SB431542 dose-dependency. H9
andMixl1-GFPhEScellsandHK1hiPScellsweredifferentiatedinthepresenceofBIO,Noggin,andvariousconcentrationsofActivinAorSB431542,and
the MEOX1 and TCF15 transcripts were quantified by RT-PCR. (B) GSK3 inhibitor, Noggin and SB431542-dependent specification of paraxial
mesoderm from Mixl1-GFP hES cells. RT-PCR was performed with MEOX1 and TCF15 primers. No, None; N, Noggin; AceBIO/Ace-BIO, Acetoxime-
BIO; CHIR, CHIR99021; MeBIO, Methyl-BIO; S, SB431542. (C, D) Time-dependent expression of NODAL and BMP4. The H9 (C, D) and Mixl1-GFP
(D) hES cells were differentiated with no factor (No), BIO or BIO 1 Noggin (BION), and subjected on the day indicated to RT-PCR.
www.nature.com/scientificreports
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generatedfromH9hEScells.H9hEScellswere differentiated underBIONconditions, andtotalprogeny(Pre)andthe KDR
2PDGFRa
1(P1,red gatein
A) and KDR
2PDGFRa
2 (P-, blue gate in A) progeny were isolated by FACS and subjected to RT-PCR (B). (C) MEOX1 protein expression. Mesodermal
www.nature.com/scientificreports
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FACS and subjected to 2D micromass culture in the presence of various
protein factors.
The KDR
2PDGFRa
1 progeny from H9 hES cells survived and
proliferated in the presence of PDGF (‘‘P’’, Fig. 4A), as did mES
cell-derivedparaxialmesoderm
15.InthepresenceofPDGF,however,
theKDR
2PDGFRa
1cellsproducedfew,ifany,sulfatedproteoglycan
(PG)-rich cartilage nodules in the micromass formed in 16 days as
assessed by dark blue staining with acid Alcian Blue (a, Fig. 4A). The
addition of TGFb3 on days 3–6 (day 6 was the standard, ‘‘PT’’,
Fig. 4A) but not days 0–3 enhanced cartilage nodule formation,
seeminglybysupportingthegrowthoftheKDR
2PDGFRa
1progeny
to the level needed for condensation and nodule formation
(b, Fig. 4A). Furthermore, when BMP4 was added on day 10, 4 days
after TGFb, conditions under which chondrogenesis from mES cell-
derived paraxial mesoderm was enhanced
15 (‘‘PTB’’, Fig. 4A), there
was a synergistic enhancement of cartilage nodule formation in
micromass culture (d, Fig. 4A). The addition of BMP4 alone
(‘‘PB’’, Fig. 4A) slightly increased the number of detectable cartilage
nodules (c, Fig. 4A). Conversely, the sorted KDR
2PDGFRa
2 cells
survived in the presence of PDGF but never produced cartilaginous
nodules in the presence of TGFb3 and/or BMP4 (data not shown).
ThekineticsofchondrogenesisfromtheisolatedKDR
2PDGFRa
1
paraxial mesodermal cells under P, PT, PB and PTB conditions were
monitored by expression of the chondroprogenitor genes NKX3.2,
SOX9andRUNX2andthechondrocyte/cartilagematrixgenesCOL2
progeny, derived from H9 hES cells in the presence of BIO 1 Noggin (BION) or BIO alone (BIO) and cultured on a chamber slide for 5 day, were
immunostained with the anti-MEOX1 antibody. The nucleoli staining pink within a blue nucleus, some of which are indicated with white arrows, are
detectableinprogenygeneratedundertheBIONcondition. IsotypecontrolsareshowninSupplementaryFig.1C.ScaleBars,50mm.(D)Time-course of
FACS analysis for MIXL1-GFP (GFP), KDR and PDGFRa expression during Mixl1-GFP hES cell differentiation induced in the presence of BIO 1 SB 1
Noggin (BIOSN). (E, F) Enrichment of paraxial mesoderm derived from other hPS cells. Mixl1-GFP hES cells and HK1 hiPS cells were differentiated
underBIOSNconditions. FromMixl1-GFPhEScells,totalEBcells(Pre)andtheGFP
1KDR
2PDGFRa
1(GFP1P1redgate)andGFP
1KDR
2PDGFRa
2
(GFP1P2 blue gate) progeny were isolated by FACS (E) and subjected to RT-PCR using the MEOX1 primers (F). From HK1 hiPS cells, only the
KDR
2PDGFRa
1 (P1) and KDR
2PDGFRa
2 (P2) progeny were accumulated (E) as in the case of H9 hES cells.
Figure 4 | Factor-dependent chondrogenesis fromthe KDR
2PDGFRa
1paraxial mesoderm-like cells from various hPS cell lines. (A)Chondrogenesis
from the H9 hES cell-derived KDR
2PDGFRa
1 paraxial mesoderm performed under P (a), PT (c), PB (d), and PTB (d) conditions in 2D micromass
culture for 16 days. (Left) Period of treatment with PDGF (P, red), TGFb3 (T, blue) and/or BMP4 (B, green) is indicated as a bar. (Right) The resulting
micromasses were stained with acid Alcian Blue. Arrows indicate small cartilage nodules. Scale bars, 500 mm. (B) Expression of chondrogenesis-specific
genesduring2DmicromasscultureoftheH9hEScell-derivedKDR
2PDGFRa
2paraxialmesodermalcellsperformedunderP,PT,PBorPTBconditions.
The resulting micromasses were subjected to RT-PCR on the day indicated with primers for the genes indicated.
www.nature.com/scientificreports
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of NKX3.2, SOX9, COL2 and COMP, which increased from day 10
(blue, Fig. 4A). However, RUNX2 expression was the highest under
PT conditions (red), suggesting the suppression of RUNX2 express-
ion and the promotion of SOX9 and NKX3.2 expression by BMP4.
The type X collagen (COL10) transcript was not detected under the
culture conditions tested. The isolated KDR
2PDGFRa
1 paraxial
mesodermal cells thus appear to be directed toward undifferentiated
/prehypertrophic chondrocyte formation under PTB conditions in
16days of micromass culture. This is asimilar result to that reported
in chick somite explant culture
16,17.
These observations were reproduced with 3D pellet culture
(Fig.5).IntheabsenceofPDGF,theKDR
2PDGFRa
1cellpelletgrew
poorly and failed to form a particle by 24 days of culture (data not
shown). In the presence of PDGF (‘‘P’’ Fig. 5A), the cells produced a
small particle containing few, if any, sulfated PG-rich cartilage
Figure 5 | Quantitative monitoring of chondrogenesis from hPS cell-derived paraxial mesoderm and adult hMSCs. (A) 3D pellet chondrogenesis
culture conditions for the sorted hPS cell progeny and the STRO1
1 hMSCs. (B) Cartilage particle formation from the KDR
2PDGFRa
1 paraxial
mesoderm-derivedfromH9andMix1-GFPhEScellsandHK1hiPScells.ChondrogenesisfromtheKDR
2PDGFRa
1progeny(P1cells,Fig.3A)fromH9
hEScellswasperformedunderP(a),PT(b),PB(c),andPTB(d–h)conditionsin3Dpelletculturefor24days.TheGFP
1KDR
2PDGFRa
1progeny(e,f)
andGFP
1KDR
2PDGFRa
2progeny(g)fromMixl1-GFPhEScells(GFP1P1andGFP1P2cells,respectively,Fig.3E)andtheKDR
2PDGFRa
1progeny
(P1cells,Fig. 3E) fromHK1 hiPScells (h)were alsopellet-cultured under PTBconditions. Theresulting cartilage particles wereparaffin-sectioned,and
stained with Toluidine blue (a–e, g, h) or immunostained with the anti-COL2 antibody (f). The arrow indicates a small cartilage nodule. Scale bars, 500
mm. (C) The COL2/COL1 protein ratio. The conditioned media of the cartilage particles formed under PT, PTB, PT/B, T, or TBconditions as indicated,
using the KDR
2PDGFRa
1 paraxial mesoderm from H9 hES cells and HK1 hiPS cells, and the STRO1
1 hMSCs from the bone marrow of donor 1
(STRO1
1MSC1),weresubjectedtoCOL1andCOL2ELISA.TherationgCOL2/ngCOL1wascalculated,averagedandplotted(shownasabar).TheSD
isshownasathinverticalline.(D)ChangeinthelevelofCOL10transcriptintheH9hEScell-derivedKDR
2PDGFRa
1paraxialmesodermbefore(Sorted
P
1) and after 3D pellet culture performed under PT and PTB conditions.
www.nature.com/scientificreports
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Toluidine Blue (a, Fig. 5B). The addition of TGFb3 on day 6 (‘‘PT’’,
Fig. 5A) enhanced cartilage nodule formation (b, Fig. 5B) and, when
followed by BMP4 on day 10 (‘‘PTB’’, Fig. 5A), resulted in marked
enhancement in pellet growth and the accumulation of intercellular
matrix that was metachromatically stained with Toluidine blue (d,
Fig. 5). Although addition of BMP4 (‘‘PB’’, Fig. 3A) resulted in a
cartilageparticlesignificantlylargerthanthatformedinthepresence
of PDGF alone (c, Fig. 5B), the sequential addition of TGFb3 and
BMP4 reproducibly gave rise to a much larger, translucent particle
filled with a cartilaginous matrix.
Chondroprogenitors can be generated from non-mesodermal cells,
such as cranial neural crest cells
18.T oc o n f i r mt h a tthe mesodermal
progeny in the KDR
2PDGFRa
1cell fractioncontributed tothe cartilage
particles, GFP
1KDR
2PDGFRa
1 paraxial mesoderm cells derived from
day 8 Mixl1-GFP EBs formed under BIOSN were sorted (GFP1P1,
Fig. 3E) and subjected to 3D pellet cultures (Fig. 5B). Under PTB
conditions, a cartilage particle that was filled with cartilaginous matrix
formed and was found to stain metachromatically with Toluidine Blue
(e, Fig. 5B) and to immunostain uniformly with a COL2 antibody (f).
However, other fractions, such as GFP
1KDR
2PDGFRa
2 cells, did not
form cartilaginous particles (g), demonstrating that the chondrogenic
activity was restricted to the KDR
2PDGFRa
1 paraxial mesodermal
cells. Cartilage formation under PTB conditions was also demonstrated
with the KDR
2PDGFRa
1 paraxial mesoderm progeny derived from
HK1 hiPS cells (P1, Fig. 3E) differentiated under BIOSN conditions
( h ,F i g .5 B ) .T h u s ,t h eP T Bc o n d i t i o n sf a c i l i t a t e dc h o n d r o c y t ef o r m a t i o n
from paraxial mesoderm-like cells generated from various hPS cell lines.
Hyaline-like cartilage formation from the isolated KDR
2PDGFRa
1
paraxial mesoderm. Cartilage is classified according to the
composition of the extracellular matrix. The translucent joint
articular cartilage is hyaline cartilage; it is rich in COL2 and PG but is
poor in COL1, i.e., PG
1COL2
1COL1
2 19. In contrast, the fibrocartilage
of the meniscus contains COL2 and a significant level of COL1 but it is
poor in PG, i.e., PG
lowCOL2
1COL1
1. In the growth plate, chondrocytes
mature into hypertrophic chondrocytes that express COL10 instead of
COL2
13,14.T G F b facilitates the initial mesenchymal condensation but
inhibits the hypertrophic differentiation of chondrocytes, whereas BMP
signaling plays additional roles in the proliferation, maintenance and
maturation of chondrocytes
20.
The degree of chondrogenesis during 3D pellet culture was moni-
tored by ELISA quantification of the amount of COL2 protein (from
chondrocytes) and COL1 protein (from undifferentiated mesenchymal
cells or chondrocytes in fibrocartilage) secreted into the culture med-
ium. As shown in Fig. 5B, under PT conditions (b, Fig. 5B), 3D pellet
culture with the KDR
2PDGFRa
1paraxialmesoderm from H9 hES cells
yielded a small particle with few small cartilage nodules. However,
under PTB conditions (d), the cartila g ep a r t i c l et h a tf o r m e dw a sb i g g e r
and was filled with cartilaginous matrix. When we determined the ratio
of COL2 protein levels and COL1 protein levels (COL2/COL1), it was
greater in the conditioned media of particles formed under the PTB and
PT/B (condition where PDGF and TGFb3 were replaced with BMP4 on
day 10, Fig. 5A) conditions than under the PT conditions (Fig. 5C).
Interestingly, there was no sign of upregulation of COL10 expression
during the 24-day 3D pellet culture under either the PT or PTB con-
ditions (Fig. 5D). Therefore, similar to the results from the 2D micro-
mass culture (Fig. 4), the chondrocytes in the cartilage particle that
formed seemed not to undergo hypertrophic differentiation under the
conditions tested.
To confirm the quantitative ELISA data, the cartilage particles
generated were subjected to immunohistochemical analyses
(Fig. 6A–C). The cartilage particle formed under PT conditions con-
sisted of heterogeneous areas: a small cartilaginous area strongly
Figure 6 | Analysis of comparative cartilage-formation by hES cell-derived paraxial mesoderm-like cells and adult bone marrow-derived hMSCs. The
H9 hES cell-derived KDR
2PDGFRa
1 paraxial mesoderm (A–C) and human bone marrow-derived STRO1
1 MSCs from donor 1 (p4, STRO1
1MSC1)
(D–G)weresubjectedto3DpelletchondrogenesiscultureunderPT(A,F),PTB(B,G),PT/B(C),T(D),andTB(E)conditions.Fourcontiguoussections
were stained with Toluidine Blue (T-Blue) (i, ii), or immunostained for COL1 (iii), COL2 (iv), or isotype control (v). (ii) shows an enlarged view of the
square in (i). Scale bars, 200 mm.
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matically (i.e. pink to purple) with Toluidine Blue, all of which were
immunostained positively for both COL1 and COL2, i.e.,
COL2
1COL1
1 (Fig. 6A). The larger, translucent cartilage particle
formed under PTB conditions consisted of a uniform cartilaginous
area that was stained metachromatically with Toluidine Blue and
immunostained strongly with COL2 (Fig. 6B-iv) but not COL1,
i.e., PG
1COL2
1COL1
2 (Fig. 6B). The PT/B conditions yielded a
similar PG
1COL2
1COL1
2 cartilage particle consisting of larger
round chondrocytes with abundant cytoplasms (Fig. 6C).
Therefore, these semi-quantitative immunohistochemical analyses
on the cartilage particles correlated well with the quantitative
ELISA analysis on the pellet culture supernatants.
Comparative analysis of chondrogenesis from adult MSCs and
hES cell-derived non-mesodermal mesenchymal cells. Next, we
compared the chondrogenic capacity of the KDR
2PDGFRa
1
human paraxial mesoderm with that of the STRO1
1 adult hMSCs
using 3D pellet culture. Under standard chondrogenic differen-
tiation conditions designed for bone marrow stromal cells (TGFb3
without BMP4 and PDGF, i.e., ‘‘T’’, Fig. 5A)
21, the STRO1
1 hMSCs
gave rise to small particles consisting of heterogeneous areas: a
cartilaginous area strongly stained and mesenchymal cell areas
weakly stained metachromatically (i.e. pink to purple) with
Toluidine Blue, which were immunostained with COL2 and COL1,
i.e., PG
1/lowCOL2
1COL1
1 (Fig. 6D, Supplementary Fig. 4A). The
results obtained with the STRO1
1 hMSCs from a different donor
are shown in Supplementary Fig. 4. The later addition of BMP4 on
day 10 (‘‘TB’’) led to the enlargement of both the particle size and the
cartilaginous area (purple), which was restricted to the periphery of
the particle. However, COL1 staining was still significant, i.e.,
PG
1COL2
1COL1
1 (Fig. 6E, Supplementary Fig. 4B). The PT
conditions resulted in a larger particle with less PG and COL2 as
judged by the lack of metachromatic staining with Toluidine Blue
(i.e. many blue stained nuclei/cells but only a very low level of pink
to purple stained intercellular matrices found) and faint COL2
immunostaining. A significant level of COL1 staining was observed,
i.e., PG
low/2COL2
lowCOL1
1 (Fig. 6F, Supplementary Fig. 4C). Even the
PTB conditions failed to support the production of a large translucent
particle, and the matrix profile remained in PG
1/lowCOL2
lowCOL1
1
(Fig. 6G, Supplementary Fig. 4D). Note that there was a slight
increase in metachromatic staining with Toluidine blue compared
with that in the particle formed under PT conditions (Fig. 6F).
Consistent with the immunohistological results, the ELISA ana-
lysis demonstrated that the COL2/COL1 protein ratio obtained dur-
ing pellet culture of STRO1
1 hMSCs under the T and TB conditions
was significant, but much lower than those obtained during hyaline-
like cartilage particle formation from the H9hES cell- and HK1hiPS
cell-derived paraxial mesoderm (i.e. under the PTB and PT/B con-
ditions, Fig. 5C). In contrast, the value obtained with the STRO1
1
hMSCs during pellet culture under the PT and PTB conditions was
negligible (Fig. 5C). The same results were obtained with the
STRO1
1 hMSCs from a different donor (Supplementary Fig. 5).
Thus, these results suggest that TGFb and BMP are crucial for the
chondrogenic differentiation of STRO1
1 hMSCs, and that PDGF
prevents the cells from forming COL2-positive COL1-poor cartilage
particles but promotes the enlargement of the particles.
It has been reported that MSC-like mesenchymal progeny can be
generated spontaneously from hES cells
5. To compare the chondro-
genic capacity of the KDR
2PDGFRa
1 paraxial mesodermal cells with
such mesenchymal cells, H9 and Mixl1-GFP hES cells were differen-
tiated, and mesenchymal cells were prepared as EB-outgrowth cells
using one of the reported methods
22 with slight modifications. This
protocol utilizes no exogenous factors during the first 8 days of EB
formation (i.e., lineage specification) culture in CDM and the follow-
ing 10 days of EB-outgrowth (i.e., mesenchymal cell generation/
expansion) culture in the KnockOut Serum Replacement (KSR)-based
serum-free medium. When Mixl1-GFP hES cells were used, there
were zero to a very small number of GFP
1 or PDGFRa
1 progeny
generated (Fig. 7A), demonstrating that mesodermal specification did
not occur. Mesenchymal cells generated in the same way from H9 hES
cells were subjected to 3D pellet chondrogenesis culture under two
conditions: TB (originally developed for MSCs) and PTB (developed
for paraxial mesoderm) (Fig. 7B). Although PDGF caused an increase
in size, the cartilaginous particles formed under either condition accu-
mulatedverylowlevelsofPG,asjudgedbytothelackof,orveryweak,
metachromatic staining with Toluidine Blue. However, significant
levels of both COL2 and COL1 were detected by immunostaining,
i.e., PG
2COL2
1COL1
1. These results suggest the presence of fibrotic
cartilage particle formation.
Figure 7 | Chondrogenicactivityofnon-mesodermalmesenchymalcellsarisingfromhEScells. Mixl1-GFP(A)andH9(B)hEScellsweredifferentiated
intheabsenceofexogenousfactors, andsubjectedtoFACSanalysis(A)andtotheEB-outgrowthculture(B),respectively.Theoutgrowthcells(p4)were
then subjected to 3D pellet culture under TB (a) and PTB (b) conditions. Four contiguous sections were stained with Toluidine Blue (T-Blue) (i), or
immunostained for COL1 (ii), COL2 (iii), or isotype control (iv). Scale bars, 200 mm.
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In this report, we have demonstrated the following: the suppression of
GSK3b activity and BMP signaling and the appropriate level of Nodal/
Activin/TGFb signaling effectively specify paraxial mesoderm from hPS
cells; FACS-isolated (Mixl1-GFP
1)KDR
2PDGFRa
1 progeny readily
form a hyaline-like cartilage particle in a serum-free medium via
sequential functions of PDGF, TGFb and BMP; and the gold standard
STRO1
1 hMSCs from adult bone marrow and non-mesodermal
mesenchymal cells from hES cells respond to these factors differently
to form particles poor in PG that express both COL2 and COL1.
Although FLK1
2PDGFRa
1 rostral paraxial mesoderm is readily
induced from mES cells with WNT3a and Noggin in CDM
8, the
derivationofparaxialmesodermfromhPScellsrequiredthereplace-
mentofWNT3awiththeGSK3binhibitorBIO.Interestingly,alower
concentrationofBIO,suchas0.5–1mM,resultedinasimilarprogeny
profile to that obtained using WNT3a at 100 ng/ml; however, the
hemoangiogenic KDR
1PDGFRa
lo population
23,24 was not generated,
and the inclusion of Noggin suppressed the accumulation of all
PDGFRa
1 progeny (i.e. only very low levels of KDR
2PDGFRa
1
progeny remained) and failed to induce the MEOX1 transcript (data
not shown). Therefore, although suppression of GSK3b will affect
many signalling pathways in addition to the WNT pathway, it is
possiblethattheefficientspecificationofparaxialmesodermrequires
a strong canonical WNT signal, and that WNT3a at 100 ng/ml fails
to satisfy such a signalling requirement in hPS cells.
ThebenefitofcombiningTGFbandBMPforrobustchondrogen-
esis in vitro has been demonstrated with the mES cell-derived meso-
dermal progeny
15 and the MSCs
25. However, the advantages of the
PDGFandTGFbcombination(‘‘PT’’)andlatertreatmentwithBMP
(‘‘PTB’’) or later transition from PDGF 1 TGFb to BMP (‘‘PT/B’’)
hadonlybeenclearlydemonstratedwiththemEScell-derived meso-
derm
15. In this respect, the hPS cell-derived paraxial mesoderm,
which shows efficient chondrogenesis under PTB conditions, is stri-
kingly similar to the mES cell-derived mesoderm. In contrast, the
adult marrow hMSCs failed to show equivalent levels of chondro-
genesis in the presence of PDGF, which stimulated the growth of the
pellets formed. These results are partly consistent with the previous
observations that PDGF signaling through PDGFRa is required for
efficient somitic chondrogenesis and limb chondrogenesis in vivo
andinvitro
26,27,whilesuchsignalinghaslittleeffectonadultarticular
chondrocytesinvivoandcausesonlyasmallincreaseinPGsynthesis
in vitro during a cartilage explant culture
28,29.
Minor bleeding, which is inevitable at the site of chondroprogeni-
tortransplantation, leadstotheformationofafibrinclot.Attheclot,
accumulated platelets are activated to release various bioactive fac-
tors, including PDGF. In such a PDGF-rich environment, the use of
hPScell-derivedchondrogenicmesodermmayproduceabetterclin-
ical outcome than the use of bone marrow hMSCs.
The mesenchymal cells generated from hES cells without exogenous
factors are known to display a limited chondrogenic activity in regular
3D pellet culture, producing fibrotic cartilage particles poor in PG but
expressing both COL2 and COL1
5.W eh a v ed e m o n s t r a t e dt h en o n -
mes(end)odermal identity of such mesenchymal cells (Fig. 7), and have
reproduced their tendency to form fibrotic cartilage particles in vitro
undertheconditionsinwhichthe hPScell-derived paraxialmesodermal
cells formed hyaline-like cartilage particles (Fig. 6). The neural origin of
the early bone marrow stromal cells has been demonstrated in the
mouse
30,31. The ‘memory’ of the developmental origin of mesenchymal
cells may dictate the type of cartilage formed during chondrogenesis.
However, it is also possible that the necessary expansion of the hMSCs
and the hEB-outgrowth cells before use may not only lead to the reduc-
tion of chondrogenic activity as seen in other cultured mesenchymal
cells
32 (Supplementary Fig. 6E–H), but also determine the type of car-
tilage the cells will tend to form.
Insummary,thesedataindicatethattheKDR
2PDGFRa
1paraxial
mesodermal cells from hPS cells are a promising alternative to adult
MSCs for the future in vitro generation of engineered hyaline cartil-
age constructs and cartilage regenerative therapy for joint disorders.
Methods
Cells, factors, and antibodies. H9 (WiCell Research Institute, Madison, WI) and
MEL1 (Stem Cell Sciences, Melbourne Australia) hES cells were maintained on
mouse embryonic fibroblasts (MEFs) as bulk culture in the KnockOut Serum
Replacement (KSR, Invitrogen, Carlsbad, CA)-based hES cell medium containing
4 ng/ml fibroblast growth factor-2 (FGF2, R&D Systems Inc., Minneapolis, MN) as
previouslydescribed
23,24.TheMixl1-GFPhEScellsweremaintainedonMEFsinKSR-
based hES cell medium with 10 ng/ml FGF2 and expanded using a trypsin-based cell
dissociationmethod aspreviouslydescribed
11.However, thecells wereadapted tothe
same maintenance conditions as those for H9 and MEL1 from 4 weeks before
differentiation. Thehuman keratinocyte-derived iPScell lineHK1,established bythe
retroviraltransductionofthefourYamanaka-factorsandNANOGtohumanprimary
hair follicle cells as previously described
33, was kindly provided by Dr. Brian Davis
(Houston TX). The HK1 cells were maintained in the same manner as the hES cells
exceptthattheconcentrationofFGF2washigher(40 ng/ml).TheBry-GFPmEScells
wereobtainedfrom Dr.GordonKeller (Toronto, Canada) and cultured as previously
described
15,34. Human bone marrow stromal cells were obtained at the University of
Adelaide according to the University of Adelaide Human Research Ethics
Committees. The preparation of mononuclear cells and purification of MSCs by
magnetic cell sorting (Miltenyi Biotec, Auburn CA) with the STRO1 antibody were
performed as previously described
35. The isolated MSCs were cultured in a-modified
Minimal Essential Medium, 2 mM GlutaMax, 1 mM Na-pyruvate (all from
Invitrogen), and they were supplemented with 20% (v/v) fetal bovine serum
(HyClone, Logan, UT). Theantibodies for FACS, cytokines, media and supplements,
buffers and specialized tissue culture plates were generally sourced as described
23,24.
MesodermaldifferentiationofPScells.HumanPScells(H9,MEL1,Mixl1-GFPand
HK1) were differentiated 3-dimensionally using the embryoid body (EB)-forming
culture. The culture was initiated in suspension in the CDM: Iscove’s modified
Dulbecco’s medium (Sigma-Aldrich, St. Louis, MO): Ham’s F12 (Invitrogen) (151),
5 mg/ml fatty acid-free bovine serum albumin (Sigma), 2% (v/v) chemically defined
lipid concentrate (Invitrogen), 2 mM GlutaMax (Invitrogen), 100 mg/ml human
holo-transferrin (Sigma), 10 mg/ml bovine insulin (Sigma), 0.45 mM
monothioglycerol (MTG, Sigma), 0.17 mM ascorbic acid-2-phosphate (AA2P,
Sigma) with the factors indicated, and they were maintained at 37uC under 5% CO2
and 5% O2
8. The EBs that developed in 3 days were transferred to a semi-solid CDM
containing 0.9% (w/v) methylcellulose (Stem Cell Technology, Vancouver, Canada)
with the factors indicated. The EBs were collected on day 8, and single EB cells were
obtained with a brief (3 min) treatment in TrypLE Select (Invitrogen). The Bry-GFP
mES cells were differentiated using the EB-forming culture in semi-solid CDM
(withoutAA2P)withthe factorsaddedonday 2ofdifferentiation,and singleEBcells
were obtained non-enzymatically with 1 mM EDTA treatment as previously
described
8. The concentration ranges of factors used was as follows: Noggin
(mNoggin-Fc, R&D) at 100–300 ng/ml, WNT3a and WNT5a (mouse proteins,
Millipore/Chemicon, Billerica, MA) at 100 ng/ml, BMP4 (hBMP4, R&D) at 10
ng/ml, Activin (hActivin A, PeproTech, Rocky Hill, NJ) at 1–20 ng/ml, BIO
(6-bromoindirubin-39-oxime), Acetoxime-BIO (AceBIO), 1-methyl-BIO (MeBIO)
(all from Calbiochem, San Diego, CA) and CHIR99021 (6-{2-[4-(2,4-Dichloro-
phenyl)-5-(4-methyl-1H-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-
nicotinonitrile, BioVision, Mountain View, CA) at 2–5 mM, and SB431542 (4-(5-
Benzol[1,3]dioxol-5-yl-4-pyrldin-2-yl-1H-imidazol-2-yl)-benzamide, Tocris
Bioscience,Ellisville,MO)at1–10mM.BIOservedasthemajormesoderminducerin
thisstudy.Duringthefirst3daysofEBculture,BIOwasaddedat2mMfortheH9hES
cellsandat3mMfortheotherhPScells(Mixl1-GFP,MEL1andHK1)inthepresence
of 100 ng/ml Noggin. When the EBs were transferred to the semi-solid medium on
day 3, BIO was supplied at 5 mM with Noggin (Fig. 1A).
EB-outgrowth culture. The mesenchymal cells were developed spontaneously from
hPS cells using one of the established EB-outgrowth methods
22 with slight
modifications. Briefly, the hPS cells were differentiated using the EB-forming culture
inCDMfor8daysintheabsenceofexogenousfactorsat37uCunderconditionsof5%
CO2 and 5% O2. The resulting EBs were transferred to a tissue culture plate and
cultured in the hES cell medium without FGF2 for 10 days to allow for attachment of
theEBstotheplateandslowoutgrowthofmesenchymalcells.Next,themesenchymal
cells were purified by selective expansion (for 3 or more passages) in Dulbecco’s
modified Eagle’s medium (DMEM, Invitrogen) supplemented with 10% (v/v) fetal
bovine serum (HyClone) and the repetitive filtering method as described
22.
Flow cytometry. Single-cell suspensions from human EBs were stained with the
mouse anti-human PDGFRa and anti-human KDR monoclonal antibodies as
previously described
23,24. The FACS analysis was performed on LSRII (BD
Biosciences, San Jose, CA), and cell sorting was performed with Aria II (BD). Viable
single cells were gated using DAPI (49,6-diamidino-2-phenylindole, Sigma). The
purity of the sorted cells ranged from 92 to 96%.
Immunofluorescence detection of paraxial mesoderm. The H9 hES cells were
differentiated in CDM in the presence of BIO 1 Noggin or BIO alone to generate
PDGFRa
1mesenchymalprogeny,whichwerefurtherculturedinan8-welllchamber
slide (Nunc, Rochester, NY) coated with human fibronectin (Sigma, at 10 mg/ml for
24 h at 4uC) for 3–5 days in CDM containing 10 ng/ml PDGF (hPDGF-BB, R&D),
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 455 | DOI: 10.1038/srep00455 10100 ng/ml Noggin, 0.1 mM CHIR99021, 0.1 mM PD173074 (Tocris), and 1 mM
SB431542 at 37uC under 5% CO2 and 5% O2. Cultures were stopped and fixed with
10% (v/v) buffered Zn-Formalin (Z-fix, Anatech, Battle Creek, MI) for 20 min at r.t.,
then immunostained with the rabbit anti- hMEOX1 polyclonal antibody (Prestige
antibody,Sigma),followedbybiotinylated anti-rabbitIgG(VectorLabs,Burlingame,
CA), and, finally, AlexaFluor 594-conjugated streptavidin (Invitrogen). The stained
slides wereinspectedwith aBX61fluorescence microscope (Olympus,Center Valley,
PA) one day after being mounted with a DAPI-containing solution (Invitrogen).
Chondrogenesis assays. Two-dimensional (2D) micromass culture was performed
with FACS-purified mesodermal progeny (1.5310
5 cells) transferred in 5 mlt oa
fibronectin-coated 24-well plate (BD) and cultured in serum-free chondrogenic
medium: DMEM: F12 (151) (Invitrogen), 1%(v/v) ITS1mix (BD), 0.17 mMAA2P,
0.35 mM Proline (Sigma), 0.1 mM dexamethasone (Sigma), 0.15% (v/v) glucose
(Sigma), 1 mM Na-pyruvate (Invitrogen), 2 mM GlutaMax, 0.05 mM MTG
8,15 and
supplemented with 40 ng/ml PDGF and 1% (v/v) fetal bovine serum (Hyclone).
TGFb3 (hTGFb3, R&D) was subsequently added at 10 ng/ml on day 3 to 6. As
indicated,BMP4wasaddedtoaconcentrationof50 ng/mlonday10.Themicromass
culturesweremaintainedat37uCunder5%CO2and5%O2for16days,fixedwithZ-
Fix, and stained with 1% (w/v) Alcian Blue (Sigma)pH1.0 (i.e.acid Alcian Blue). For
3-dimensional (3D) pellet culture, 3.0310
5 FACS-purified EB cells, EB-outgrowth
cellsatpassage4to5,andadult MSCsatpassage 4to8werecentrifuged andcultured
as a pellet in 0.5 ml of the serum-free chondrogenic media
8,15 that was supplemented
withthe definedfactors addedin the same sequence as in the micromass culture. The
pellet cultures were maintained at 37uC under 5% CO2 for 24 days, fixed with
Gendre’sFluid,paraffin-embedded,sectioned,andstainedwith0.1%(w/v)Toluidine
Blue(Sigma)orimmunostainedwithanti-typeI(COL1)andtypeII(COL2)collagen
antibodies, followed by color development in the presence of horseradish peroxidase
and 3, 39-diaminobenzidine as described
8,15.
Quantitative comparison of collagen production. During 3D pellet culture, media
conditioned with cartilage particles for3days werecollected onday 24,and thelevels
of COL1 and COL2 proteins were quantified with ELISA kits (MD Biosciences, St.
Paul, MN) according to the manufacturer’s recommendation. The proportion of
COL2 to COL1 production (ng COL2/ng COL1) was calculated from duplicate or
triplicate reactions and averaged to obtain a measure of the extent of chondrogenesis
by the undifferentiated mesenchymal cells used for 3D pellet culture.
Gene-expression profiling. Total RNA from the whole differentiated progeny or
FACS-purified progeny was purified and reverse transcribed (RT). Real-time polymerase
chain reaction (PCR) was then performed using the Taqman Gene Expression Assay and
ABI7900 (Applied Biosystems, Foster City, CA) as previously described
23. The individual
gene expression levels from duplicate or triplicate reactions were normalized against the
EEF1A1 transcript and averaged to obtain relative expression data. The real-time RT-
PCR results are presented as average relative expression levels in a bar or line graph. The
standard deviation (SD) is shown as a thin vertical line.
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